Women prescribed the antiemetic agent metoclopramide during pregnancy appear to be at no significantly increased risk for adverse outcomes, including spontaneous abortion, stillbirth, and infants with ...
Metoclopramide use during early pregnancy was not associated with excess risk for congenital malformations. In the U.S., treatment of nausea and vomiting during early pregnancy usually involves ...
BEER-SHEVA, ISRAEL, June 10, 2009 – Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published ...
Metoclopramide Orally Disintegrating Tabs prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.
SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an ...
Metoclopramide, a central and peripheral dopamine type 2 receptor antagonist, has been used as an attractive and safer alternative to cisapride. To evaluate the effects of intravenous metoclopramide ...
Late last month, the Food and Drug Administration ruled that makers of the drug metoclopramide must put the strongest so-called black-box warning on the product’s package insert. Also sold as Reglan, ...
Metoclopramide is a central dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in dogs and cats 1,2,3,4. It has been used experimentally in pigeons as an antiemetic agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback